CXCL9 and prostate neoplasm: However, we found that ARID1A loss did not reduce Cxcl9 and Cxcl10 expression in PCa cells treated with IFN-γ or TNF-α and mouse prostate tumors (Supplementary Fig. 3f, h, i).